KAS
CNSY

Kestra Advisory Services’s Cerenome CNSY Stock Holding History

Kestra Advisory Services’s Portfolio CNSY Stock Details CNSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,032
Closed -$4.2K – 3349
2026
Q1 		$4.2K Hold
1,032
– – ﹤0.01% 3110
2025
Q4 		$13.2K Hold
1,032
– – ﹤0.01% 4531
2025
Q3 		$17.6K Buy
+1,032
New +$12.7K ﹤0.01% 2885

Other funds holding CNSY

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Kestra Advisory Services's CNSY Position: Q2 2026 in Review

Kestra Advisory Services sold out of Cerenome (CNSY) in Q2 2026, closing a stake of 1,032 shares — an estimated $4.2K sold.

Kestra Advisory Services first reported a position in CNSY in Q3 2025 and held it in 3 quarters. The position peaked at $17.6K in Q3 2025. 21 funds tracked by Wall St. Rank hold CNSY as of Q2 2026.

  • Kestra Advisory Services reported no remaining Cerenome position as of Q2 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 1,032 Cerenome shares in Q2 2026, an estimated $4.2K.
  • Kestra Advisory Services first reported a position in Cerenome in Q3 2025 and held it in 3 quarters.
  • Kestra Advisory Services's Cerenome position peaked at $17.6K in Q3 2025.
  • 21 funds tracked by Wall St. Rank held Cerenome as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.